AAAAAA
Results: 1-25/72
Authors:
OERTEL R
RICHTER K
GRAMATTE T
KIRCH W
Citation: R. Oertel et al., DETERMINATION OF DRUGS IN BIOLOGICAL-FLUIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ONLINE SAMPLE PROCESSING, Journal of chromatography, 797(1-2), 1998, pp. 203-209
Authors:
EICHHORN A
KIRCH W
Citation: A. Eichhorn et W. Kirch, SICCA (SJOGRENS) SYNDROME AND HEARING-LOS S WITH BEHCETS-SYNDROME, Deutsche Medizinische Wochenschrift, 123(21), 1998, pp. 663-666
Authors:
GROSSMANN M
JAMIESON MJ
EBERT U
KIRCH W
Citation: M. Grossmann et al., INVOLVEMENT OF H-1-RECEPTOR AND H-2-RECEPTOR IN THE HISTAMINE RESPONSE OF THE HUMAN FOREARM VASCULATURE, Journal of vascular research, 35, 1998, pp. 277-277
Authors:
EBERT U
OERTEL R
WESNES KA
KIRCH W
Citation: U. Ebert et al., EFFECTS OF PHYSOSTIGMINE ON SCOPOLAMINE-INDUCED CHANGES IN QUANTITATIVE ELECTROENCEPHALOGRAM AND COGNITIVE PERFORMANCE, Human psychopharmacology, 13(3), 1998, pp. 199-210
Authors:
SCHWEIZER J
KIRCH W
KOCH R
HELLNER G
UHLMANN K
Citation: J. Schweizer et al., EFFECT OF HIGH-DOSE VERAPAMIL ON RESTENOSIS AFTER PERIPHERAL ANGIOPLASTY, Journal of the American College of Cardiology, 31(6), 1998, pp. 1299-1305
Authors:
EBERT U
SIEPMANN M
OERTEL R
WESNES KA
KIRCH W
Citation: U. Ebert et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF SCOPOLAMINE AFTER SUBCUTANEOUS ADMINISTRATION, Journal of clinical pharmacology, 38(8), 1998, pp. 720-726
Authors:
OERTEL R
SCHWARZ U
KIRCH W
Citation: R. Oertel et al., IN-VITRO INVESTIGATION OF THE INTERACTION S OF TALINOLOL WITH DIFFERENT ERYTHROMYCIN PREPARATIONS AND SUBSTANCES, Die Pharmazie, 53(4), 1998, pp. 277-278
Authors:
SCHWARZ UI
KRAPPWEIS J
STOELBEN S
KIRCH W
Citation: Ui. Schwarz et al., DRUG INFORMATION-SERVICES - INITIAL EXPERIENCES IN DRESDEN, European Journal of Clinical Pharmacology, 54(8), 1998, pp. 667-668
Authors:
HOOGKAMER JFW
KLEINBLOESEM CH
OUWERKERK M
HOGEMANN A
NOKHODIAN A
KIRCH W
WEIDEKAMM E
Citation: Jfw. Hoogkamer et al., PHARMACOKINETICS AND SAFETY OF CANDESARTAN CILEXETIL IN SUBJECTS WITHNORMAL AND IMPAIRED LIVER-FUNCTION, European Journal of Clinical Pharmacology, 54(4), 1998, pp. 341-345
Authors:
GROSSMANN M
BRAUNE J
EBERT U
KIRCH W
Citation: M. Grossmann et al., DILATORY EFFECTS OF PHOSPHODIESTERASE INHIBITORS ON HUMAN HAND VEINS IN-VIVO, European Journal of Clinical Pharmacology, 54(1), 1998, pp. 35-39
Authors:
HOOGKAMER JFW
KLEINBLOESEM CH
NOKHODIAN A
OUWERKERK MJA
LANKHAAR G
UNGETHUM W
KIRCH W
Citation: Jfw. Hoogkamer et al., PHARMACOKINETICS OF IMIDAPRIL AND ITS ACTIVE METABOLITE IMIDAPRILAT FOLLOWING SINGLE-DOSE AND DURING STEADY-STATE IN PATIENTS WITH CHRONIC-RENAL-FAILURE, European Journal of Clinical Pharmacology, 54(1), 1998, pp. 59-61
Authors:
EBERT U
KIRCH W
Citation: U. Ebert et W. Kirch, INTERACTION OF ANTICOAGULANTS AND CARDIOV ASCULAR DRUGS, Der Internist, 39(5), 1998, pp. 537-542
Authors:
GROSSMANN M
JAMIESON MJ
KIRCH W
Citation: M. Grossmann et al., EFFECTS OF DIGOXIN AND DIGITOXIN ON CIRCADIAN BLOOD-PRESSURE PROFILE IN HEALTHY-VOLUNTEERS, European journal of clinical investigation, 28(9), 1998, pp. 701-706
Authors:
GROSSMANN M
DOBREV D
KIRCH W
Citation: M. Grossmann et al., AMIODARONE CAUSES ENDOTHELIUM-DEPENDENT VASODILATION IN HUMAN HAND VEINS IN-VIVO, Clinical pharmacology and therapeutics, 64(3), 1998, pp. 302-311
Authors:
GROSSMANN M
DOBREV D
NEIDHARDT B
KIRCH W
Citation: M. Grossmann et al., AMIODARONE-MEDIATED VASODILATION IN HUMAN HAND VEINS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 10-10
Authors:
KRAPPWEIS JK
RENTSCH A
SCHWARZ U
KIRCH W
Citation: Jk. Krappweis et al., DRUG UTILIZATION EVALUATION IN OSTEOPOROSIS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 29-29
Authors:
EBERT U
OERTEL R
SICKOR S
KIRCH W
Citation: U. Ebert et al., PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF CNS EFFECTS OF SCOPOLAMINE IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 66-66
Authors:
PETEREIT G
KIRCH W
PETERS WHM
ROELOFS HMJ
HOENSCH H
Citation: G. Petereit et al., INFLUENCE OF DRUG INTAKE TO THE GLUTATHIONE SYSTEM OF HUMAN GASTROINTESTINAL MUCOSA, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 70-70
Authors:
SIEPMANN M
RAO BR
KIRCH W
Citation: M. Siepmann et al., DISPOSITION, ELIMINATION AND HEMODYNAMIC-EFFECTS OF VERAPAMIL AND TRANDOLAPRIL IN PATIENTS WITH FATTY LIVER-DISEASE, Clinical drug investigation, 14(5), 1997, pp. 376-382
Authors:
RAO BR
PETEREIT G
EBERT U
KIRCH W
Citation: Br. Rao et al., INFLUENCE OF CARBIMAZOLE ON SERUM LEVELS AND HEMODYNAMIC-EFFECTS OF DIGOXIN, Clinical drug investigation, 13(6), 1997, pp. 350-354
Authors:
DEZEEUW D
REMUZZI G
KIRCH W
Citation: D. Dezeeuw et al., PHARMACOKINETICS OF CANDESARTAN CILEXETIL IN PATIENTS WITH RENAL OR HEPATIC IMPAIRMENT, Journal of human hypertension, 11, 1997, pp. 37-42
Authors:
OERTEL R
RAHN R
KIRCH W
Citation: R. Oertel et al., CLINICAL PHARMACOKINETICS OF ARTICAINE, Clinical pharmacokinetics, 33(6), 1997, pp. 417-425
Authors:
KRONIG B
PITTROW DB
KIRCH W
WELZEL D
WEIDINGER G
Citation: B. Kronig et al., DIFFERENT CONCEPTS IN FIRST-LINE TREATMENT OF ESSENTIAL-HYPERTENSION - COMPARISON OF A LOW-DOSE RESERPINE-THIAZIDE COMBINATION WITH NITRENDIPINE MONOTHERAPY, Hypertension, 29(2), 1997, pp. 651-658
Authors:
SIEPMANN M
KIRCH W
Citation: M. Siepmann et W. Kirch, CORONARY ANOMALY IN BEHCETS-SYNDROME, Rheumatology international, 17(1), 1997, pp. 39-42
Authors:
EBERT U
LOFFLER H
KIRCH W
Citation: U. Ebert et al., CYTOTOXIC THERAPY AND PREGNANCY, Pharmacology & therapeutics, 74(2), 1997, pp. 207-220